FDA Commissioner Stephen Hahn last week fired a senior public relations staffer at the agency, as the agency faced pushback over claims Hahn made regarding convalescent plasma as an experimental treatment for Covid-19, in today's bite-sized hospital and health industry news from California, Maryland, and Pennsylvania.
Even as former hot spots for the new coronavirus in the United States have started showing signs of improvement, areas in the Midwest are now reporting accelerating numbers of new cases—a trend of "rolling" hot spots that may indicate the country is on track to face a long-sustained epidemic, public health experts say.
The most commonly used type of coronavirus test in America could be generating positive results for people who might not be contagious, according to some public health experts—but the experts say that doesn't necessarily mean the country should be testing less, Apoorva Mandavilli reports for the New York Times.
It can be difficult for organizations to identify implicit bias within their workforce, but it's critical to do so to boost overall diversity, equity, and inclusion. Advisory Board's Alexander Polyak shares how collecting and assessing workforce data can provide tangible evidence and create a solid foundation for improving equity.
FDA Commissioner Stephen Hahn said the agency could authorize use of a coronavirus vaccine candidate before phase three clinical trials are completed—a statement that comes amid controversy over whether some of the agency's recent moves have been influenced by political pressure.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.